MYUNGMOON Pharm co.,Ltd (017180.KS)
KRW 1860.0
(-0.59%)
KRW 1860.0
(-0.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 169.56 Billion | 152.13 Billion | 137.75 Billion | 127.85 Billion | 149.34 Billion | 147.49 Billion |
| Cost of Revenue | 75.05 Billion | 74.03 Billion | 75.42 Billion | 78.86 Billion | 80.91 Billion | 73.04 Billion |
| Gross Profit | 94.51 Billion | 78.1 Billion | 62.33 Billion | 48.99 Billion | 68.43 Billion | 74.45 Billion |
| Operating Expenses | 93.55 Billion | 71.66 Billion | 68.21 Billion | 77.95 Billion | 82.72 Billion | 69.51 Billion |
| Selling, General and Administrative Expenses | 72.47 Billion | 47.33 Billion | 45.53 Billion | 31.49 Billion | 25.92 Billion | 25.69 Billion |
| Research and Development Expenses | 2.96 Billion | 1.71 Billion | 2.06 Billion | 535.05 Million | 676.46 Million | 140.57 Million |
| Other Expenses | 18.94 Billion | 22.62 Billion | 20.62 Billion | 45.93 Billion | 56.12 Billion | 1.64 Billion |
| Cost and Expenses | 168.6 Billion | 145.7 Billion | 143.64 Billion | 156.81 Billion | 163.64 Billion | 142.56 Billion |
| Operating Income | 963.76 Million | 6.43 Billion | -5.88 Billion | -28.96 Billion | -14.29 Billion | 4.93 Billion |
| Interest Expense | 5.13 Billion | 3.73 Billion | 3.04 Billion | 4.14 Billion | 4.58 Billion | 3.24 Billion |
| Income Tax Expense | 92.6 Million | -5.32 Billion | 206.13 Million | 458.5 Million | 1.64 Billion | 1.56 Billion |
| Earnings before Tax | -4.78 Billion | 2.65 Billion | -6.59 Billion | -27.29 Billion | -19.18 Billion | 1.89 Billion |
| Net Income | -4.52 Billion | 7.86 Billion | -6.8 Billion | -27.75 Billion | -20.83 Billion | 988.26 Million |
| Earnings Per Share Basic | -134.35 | 232.74 | -201.27 | -948.05 | -832.04 | 39.94 |
| Earnings Per Share Diluted | -134.35 | 232.74 | -201.27 | -948.05 | -832.04 | 39.94 |
| Weighted Average Shares Outstanding | 33.67 Million | 33.8 Million | 33.8 Million | 29.27 Million | 25.03 Million | 24.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.67 Million | 33.8 Million | 33.8 Million | 29.27 Million | 25.03 Million | 24.74 Million |
| Gross Margin | 0.56 | 0.51 | 0.45 | 0.38 | 0.46 | 0.50 |
| EBIT Margin | 0.03 | 0.07 | -0.00 | -0.18 | -0.06 | 0.06 |
| Profit Margin | -0.03 | 0.05 | -0.05 | -0.22 | -0.14 | 0.01 |
| EBITDA | 4.52 Billion | 10.57 Billion | 345.37 Million | -19.35 Billion | -10.94 Billion | 7.05 Billion |
| Earnings Before Tax Margin | 0.01 | 0.04 | -0.04 | -0.23 | -0.10 | 0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 46.08 Billion | 44.23 Billion | 42.84 Billion | 169.56 Billion | 43.2 Billion | 43.5 Billion |
| Cost of Revenue | 20.24 Billion | 18.41 Billion | 19.91 Billion | 75.05 Billion | 18.92 Billion | 18.57 Billion |
| Gross Profit | 25.83 Billion | 25.82 Billion | 22.93 Billion | 94.51 Billion | 24.28 Billion | 24.93 Billion |
| Operating Expenses | 26.5 Billion | 26.76 Billion | 25.2 Billion | 93.55 Billion | -24.39 Billion | -23.55 Billion |
| Selling, General and Administrative Expenses | 25.72 Billion | 24.49 Billion | 24.09 Billion | - | 24.39 Billion | 23.55 Billion |
| Research and Development Expenses | 512.8 Million | 1.95 Billion | 707.29 Million | - | 550.31 Million | 1.17 Billion |
| Other Expenses | -262.82 Million | -312.73 Million | -404.67 Million | -1.35 Billion | -48.79 Billion | -47.11 Billion |
| Cost and Expenses | 46.75 Billion | 45.17 Billion | 45.12 Billion | 168.6 Billion | 18.92 Billion | 18.57 Billion |
| Operating Income | -671.25 Million | -941.27 Million | -2.27 Billion | 963.76 Million | -113.04 Million | 1.37 Billion |
| Interest Expense | 1.37 Billion | 1.33 Billion | 1.38 Billion | 5.13 Billion | 1.19 Billion | 1.3 Billion |
| Income Tax Expense | 12.87 Million | -702.75 Million | -94 Million | 92.6 Million | -211.25 Million | 199.34 Million |
| Earnings before Tax | -1.64 Billion | -2.11 Billion | -4.26 Billion | -4.78 Billion | -1.2 Billion | 107.49 Million |
| Net Income | -1.53 Billion | -1.21 Billion | -4.03 Billion | -4.52 Billion | -938.89 Million | -136.94 Million |
| Earnings Per Share Basic | -45.77 | -36.21 | -120.25 | - | -27.94 | -4.05 |
| Earnings Per Share Diluted | -45.77 | -36.21 | -120.25 | - | -27.94 | -4.05 |
| Weighted Average Shares Outstanding | 33.52 Million | 33.52 Million | 33.52 Million | 33.67 Million | 33.6 Million | 33.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.52 Million | 33.52 Million | 33.52 Million | 33.67 Million | 33.6 Million | 33.79 Million |
| Gross Margin | 0.56 | 0.58 | 0.54 | 0.56 | 0.56 | 0.57 |
| EBIT Margin | 0.00 | -0.00 | -0.03 | - | 0.56 | 0.57 |
| Profit Margin | -0.03 | -0.03 | -0.09 | -0.03 | -0.02 | -0.00 |
| EBITDA | 200.27 Million | -60.47 Million | -1.38 Billion | - | 24.28 Billion | 24.93 Billion |
| Earnings Before Tax Margin | -0.01 | -0.02 | -0.05 | 0.01 | -0.00 | 0.03 |
NEWCAP
URB-A
ALPA
UTL
TCPLPACK
BNBR3